Workshop on Health and Economic Impact of Influenza
Influenza Burden of Disease and Economic Analysis
Indonesia – 5-7 June 2012
The World Health Organization (WHO), the U.S. Department of Health, and Human Services (HHS) and other like-minded organizations and governments are committed to assisting in the creation of regionally-based, independent and sustainable vaccine production capacity in developing countries through capacity building and technology transfer. As a means of initiating a coordinated discussion among the international partners regarding this shared goal, WHO and HHS convened the Sustainable Influenza Vaccine Production Capacity Stakeholders’ Workshop in Washington D.C. in January 2010. During the workshop discussions a constantly recurring theme was the notion that international support for establishing or strengthening vaccine production capacity in developing countries must also include appropriate efforts to strengthen regional capacity to collect the data needed to enable policy makers to make informed decisions regarding vaccines supply, demand and up-take.
Building upon the Stakeholders’ Workshop, WHO and HHS developed a Workshop on Health and Economic Impact of Influenza - Influenza Burden of Disease and Economic Analyses. Burden of disease studies and economic analyses of influenza are some of the most important short-term (next two years) investments to support increasing sustainable influenza vaccine production capacity in developing countries in the mid to long-term (3-15 years). It is considered crucial to provide policy makers with evidence of the impact of influenza on non-health sectors of society such as the national economy to allow the setting up of cost-effective preventive measures such as vaccination policies and promotion for seasonal influenza vaccine uptake.
The Workshop on Health and Economic Impact of Influenza provided relevant stakeholders the opportunity: to identify essential needs and current gaps in data collection and analysis systems in developing countries; to learn what is required to arrive at a reliable and methodologically sound burden of disease study and analysis of the impact of influenza on national economies; to discuss the development of a coordinated approach to address possible gaps in the system; to identify specific next steps to define evidence-based and cost-effective policies to prevent the impact of influenza on the economy; to discuss ideas for leveraging existing resources at regional and national level; and to identify ways to engage or re-engage with international partners on this issue.
The series of workshops was designed to support and inform the implementation of the WHO Global Pandemic Influenza Action Plan to Increase Vaccine Supply (GAP-2, as updated in July 2011). The updated implementation plan aligns a timeline to stakeholder roles and responsibilities in the creation of sustainable influenza vaccine production capacity worldwide. Outputs from the workshop are intended and expected to serve and influence the implementation of the GAP-2.